Skip to main content
. 2010 Mar 17;2010(3):CD008272. doi: 10.1002/14651858.CD008272.pub2

Comparison 1. Early ART versus standard or deferred ART (CD4 ≤ 200 or CD4 ≤ 250 cells/µl).

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Death 2 1065 Risk Ratio (M‐H, Random, 95% CI) 0.26 [0.11, 0.62]
2 Tuberculosis 2 1065 Risk Ratio (M‐H, Random, 95% CI) 0.54 [0.26, 1.12]
3 Disease progression measured by opportunistic disease 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected
4 Any Grade 3 or 4 adverse events ITT analysis 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected
5 Grade 3 or 4 anaemia Per Protocol analysis 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected
HHS Vulnerability Disclosure